Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies

Genes Chromosomes and Cancer

Volumn 25, Issue 2, 1999, Pages 176-183

  Miyagawa, Kiyoshi ^a   Hayashi, Yasuhide ^b   Fukuda, Toshikatsu ^a   Mitani, Kinuko ^b   Hirai, Hisamaru ^b   Kamiya, Kenji ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER GENETICS; CHILDHOOD CANCER; CHROMOSOME TRANSLOCATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENES, WILMS TUMOR; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MUTATION; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; WT1 PROTEINS;

EID: 0032933499     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199906)25:2<176::AID-GCC14>3.0.CO;2-F     Document Type: Article

References (28)

1. Algar E, Blackburn D, Kromykh T, Taylor G, Smith P. 1997. Mutation analysis of the WT1 gene in sporadic childhood leukemia. Leukemia 11:110-113.
2. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard BL. 1992. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40:85-97.
3. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520.
4. Carapeti M, Goldman JM, Cross NCP. 1997. Dominant-negative mutations of the Wilms' tumour predisposing gene (WT1) are infrequent in CML blast crisis and de novo acute leukaemia. Eur J Haematol 58:346-349.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III. 1992. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257:674-678.
7. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR, Haber DA. 1995. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662-4675.
8. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP. 1990. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778.
9. Kennedy D, Ramsdale T, Mattick J, Little M. 1996. An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modeling. Nat Genet 12:329-331.
10. King-Underwood L, Renshaw J, Pritchard-Jones K. 1996. Mutations in the Wilms' tumor gene WT1 in leukemias. Blood 87:2171-2179.
11. King-Underwood L, Pritchard-Jones K. 1998. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 91:2961-2968.
12. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. 1993. WT-1 is required for early kidney development. Cell 74:679-691.
13. Larsson SH, Charlieu J-P, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND. 1995. Subnuclear localization of WT1 in splicing or transcription factor domains regulated by alternative splicing. Cell 81:391-101.
14. Little MH, Prosser J, Condie A, Smith PJ, van Heyningen V, Hastie ND. 1992 Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 89:4791-4795.
15. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, van Heyningen V. 1993. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominantnegative fashion. Hum Mol Genet 2:259-264.
16. Miwa H, Beran M, Saunders F. 1992. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6:405-409.
17. Miyagawa K, Kent J, Moor A, Charlieu J-P, Little M, Williamson KA, Kelsey A, Brown KW, Hassam S, Briner J, Hayashi Y, Hirai H, Yazaki Y, van Heyningen V, Hastie ND. 1998. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour. Nat Genet 18:15-17.
18. Murata Y, Kudo T, Sugiyama H, Toyoshima K, Akiyama T. 1997. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Letters 409:41-45.
19. Pavletich NP, Pabo CO. 1991. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 Å. Science 252:809-817.
20. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber D, Housman D. 1991. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447.
21. Phelan SA, Lindberg C, Call KM. 1994. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ 5:677-686.
22. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastie ND. 1990. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346:194-197.
23. Pritchard-Jones K, Renshaw J, King-Underwood L. 1994. The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient. Hum Mol Genet 3:1633-1637.
24. Rauscher FJ III, Morris JF, Tournay OE, Cook DM, Curran T. 1990. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259-1262.
25. Sekiya M, Adachi M, Hinoda Y, Imai K, Yachi A. 1994. Downregulation of Wilms' tumor gene (wt1) during myelomonocytie differentiation in HL60 cells. Blood 83:1876-1882.
26. Smith SI, Weil D, Johnson GR, Boyd AW, Li CL. 1998. Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells. Blood 91:764-773.
27. Svedberg H, Chylicki K, Baldetorp B, Rausche FJ III, Gullberg U. 1998 Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene 16:925-932.
28. Varanasi R, Bardeesy N, Ghahremani M, Petruzzi M-J, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J. 1994. Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 91:3554-3558.